Pancreatic cancer is challenging to diagnose early because it often does not cause noticeable symptoms in its early stages. However, if a person experiences signs and symptoms that might indicate pancreatic cancer, doctors will conduct a series of tests to confirm the diagnosis and determine the extent (stage) of the disease. These tests range from imaging scans to blood tests and biopsies.
Medical History and Physical Examination
The first step in diagnosing pancreatic cancer involves a detailed medical history and physical exam:
- The doctor will ask about symptoms, risk factors (such as smoking and family history), and any other relevant medical conditions.
- A physical examination will look for jaundice (yellowing of the skin and eyes) and abnormal swelling in the liver or gallbladder.
- If abnormal findings are detected, the doctor will order further tests or refer the patient to a gastroenterologist (a specialist in digestive system diseases).
Imaging Tests
Imaging tests help doctors visualize the pancreas, detect tumors, and determine the spread of cancer.
Computed Tomography (CT) Scan
A CT scan provides detailed cross-sectional images of the body and is commonly used to diagnose pancreatic cancer. A specialized pancreatic protocol CT scan uses contrast dye to enhance the visibility of the pancreas. This helps determine:
- Whether a tumor is present
- If the cancer has spread to nearby organs, lymph nodes, or distant areas
- Whether surgery is a viable treatment option
Magnetic Resonance Imaging (MRI)
MRI scans use radio waves and strong magnets to create detailed images. Though CT scans are preferred, MRI scans may be used in certain cases, particularly to detect smaller cancerous spots in the liver.
Special types of MRI scans include:
- MR Cholangiopancreatography (MRCP): Focuses on the bile and pancreatic ducts
- MR Angiography (MRA): Maps blood vessels in the pancreas
Ultrasound
Ultrasound uses sound waves to create images of the pancreas. The two main types include:
- Abdominal ultrasound – A simple, non-invasive test that may be done initially but is less detailed than a CT scan.
- Endoscopic ultrasound (EUS) – A more accurate method using a small probe on an endoscope inserted through the throat. It helps diagnose and stage pancreatic cancer and allows for biopsy collection.
Cholangiopancreatography (Imaging of Bile and Pancreatic Ducts)
These imaging tests check for blockages or abnormalities in the bile and pancreatic ducts:
- Endoscopic Retrograde Cholangiopancreatography (ERCP): An endoscope is inserted through the throat, allowing the doctor to view the bile ducts and obtain biopsy samples. A stent may be placed to keep ducts open.
- Magnetic Resonance Cholangiopancreatography (MRCP): A non-invasive MRI scan that provides similar images without requiring a contrast dye or endoscopy.
- Percutaneous Transhepatic Cholangiography (PTC): A needle is inserted through the skin into the bile duct to inject contrast dye for X-ray imaging. This test is used when ERCP is not possible.
Positron Emission Tomography (PET) Scan
A PET scan involves injecting a radioactive sugar that accumulates in cancer cells, allowing a special camera to detect areas of high activity. A PET/CT scan combines PET and CT images for more precise tumor staging, helping determine if the cancer has spread beyond the pancreas.
Blood Tests
Blood tests help assess liver function, detect tumor markers, and evaluate a patient’s overall health.
Liver Function Tests
These tests measure bilirubin levels to determine if jaundice is caused by liver disease or a bile duct blockage, which could indicate pancreatic cancer.
Tumor Markers
Certain substances in the blood, known as tumor markers, can sometimes be elevated in pancreatic cancer patients:
- CA 19-9: The most commonly used marker, but not always reliable for early diagnosis.
- Carcinoembryonic antigen (CEA): Sometimes used but less specific for pancreatic cancer.
Though tumor markers alone cannot confirm pancreatic cancer, they are helpful for monitoring treatment response and checking for recurrence after surgery.
Other Blood Tests
Additional tests, such as a complete blood count (CBC) and chemistry panel, help assess general health and organ function before major treatments like surgery.
Biopsy (Tissue Sample Testing)
A biopsy is the only definitive way to confirm pancreatic cancer. Different biopsy techniques are used depending on tumor location and accessibility.
Types of Biopsies:
- Fine Needle Aspiration (FNA): A thin needle is inserted through the skin to extract tissue, guided by CT scan or ultrasound.
- Endoscopic Biopsy: Tissue samples are taken using EUS or ERCP during an endoscopy.
- Surgical Biopsy (Laparoscopy): A small incision is made to examine the pancreas and take tissue samples. This is usually done when cancer is suspected to have spread.
In some cases, if imaging strongly suggests cancer and surgery is planned, a biopsy may not be needed before surgery. However, if chemotherapy or radiation therapy is required before surgery, a biopsy is essential.
Genetic Testing and Biomarker Analysis
If pancreatic cancer is confirmed, additional genetic tests may be performed on the biopsy sample to look for mutations in specific genes (e.g., BRCA1, BRCA2, KRAS, HER2). These genetic markers can influence treatment decisions, particularly when targeted therapy or immunotherapy is being considered.
Additionally, individuals with a family history of pancreatic cancer may be advised to undergo genetic counseling and testing to assess their risk.
Conclusion
Diagnosing pancreatic cancer involves a combination of imaging tests, blood tests, and biopsies to confirm the presence of cancer and determine its stage. Early detection remains a challenge, but advancements in imaging and biomarker testing are improving diagnostic accuracy. If pancreatic cancer is suspected, seeking prompt medical evaluation can lead to earlier diagnosis and better treatment options.
